Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Myriad Genetics Inc (NQ: MYGN )

26.61 USD UNCHANGED
Streaming Delayed Price Updated: 5:16 PM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Myriad Genetics Inc

< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc.
Brooklyn ImmunoTherapeutics announces the appointment of Dennis H. Langer to the Company’s Board as an independent Director 
From Business Wire News Releases
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VAR QGEN GLTO
From Benzinga
Sera Prognostics Appoints Robert G. Harrison as Chief Information Officer
From GlobeNewswire News Releases
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders
From GlobeNewswire News Releases
MYRIAD GENETICS ALERT: Bragar Eagel & Squire, P.C. Announces the Shareholder Class Action Against Myriad Genetics, Inc. Survives Motion to Dismiss and Encourages Long-term Investors to Contact the Fir
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that the Shareholder Class Action Against Myriad Genetics, Inc. (NASDAQ: MYGN) has survived the motions to... 
From Business Wire News Releases
The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TNXP IBB GNMK
From Benzinga
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
Strategic collaboration combines germline genetic testing, next-generation tumor sequencing and world-class testing capabilities to elevate global precision oncology care 
From GlobeNewswire News Releases
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GKOS BVS ICPT
From Benzinga
Myriad Genetics Inc (MYGN) Q2 2021 Earnings Call Transcript
MYGN earnings call for the period ending December 31, 2020. 
Tags MYGN Market News
From Motley Fool
Recap: Myriad Genetics Q2 Earnings
Shares of Myriad Genetics (NASDAQ:MYGN) were unchanged inafter-market trading after the company reported Q2 results. Quarterly ... 
Tags Benzinga Earnings Market News
From Benzinga
Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
From GlobeNewswire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Top Stories OFIX TBPH
From Benzinga
Earnings Scheduled For February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ... 
Tags HEP Earnings Scheduled FI
From Benzinga
A Preview Of Myriad Genetics's Earnings
Myriad Genetics (NASDAQ:MYGN) will be releasing its next round of earnings this Tuesday, February 23. For all of the relevant ... 
Tags Market News Earnings Benzinga
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags ICUI COLL NEO
From Benzinga
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives
New talent and promotions span core businesses, transformation, IT, revenue cycle management, business development, marketing, legal 
From GlobeNewswire News Releases
Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021
From GlobeNewswire News Releases
New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate Cancer
Results from second study cite Prolaris® as most clinically significant prognostic parameter of outcomes at time of diagnosis, identifying men who need aggressive hormonal treatment and those who can... 
From GlobeNewswire News Releases
Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences
From GlobeNewswire News Releases
GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels
From GlobeNewswire News Releases
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MYGN RHHBY CCCC
From Benzinga
Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis
From GlobeNewswire News Releases
First Week of MYGN August 20th Options Trading
Investors in Myriad Genetics, Inc. (MYGN) saw new options become available this week, for the August 20th expiration.. 
Tags Stocks
From Market News Video
Myriad Genetics, Inc. (NASDAQ:MYGN) Investor Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 01/25/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Myriad Genetics, Inc. 
From SBWire - Latest Press Releases
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Myriad Genetics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of... 
From PR Newswire
Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
From GlobeNewswire News Releases
The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DVA VINC SLN
From Benzinga
Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International Operations
Focus on Women’s Health, Oncology, Mental Health to Improve Execution and Accelerate Growth 
From GlobeNewswire News Releases
Myriad Genetics CEO Paul J. Diaz to Present at 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
IBD Rating Upgrades: Myriad Genetics Flashes Improved Relative Price Strength
A Relative Strength Rating upgrade for Myriad Genetics shows improving technical performance. Will it continue? 
From Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.